Cipher Pharmaceuticals Inc
TSX:CPH

Watchlist Manager
Cipher Pharmaceuticals Inc Logo
Cipher Pharmaceuticals Inc
TSX:CPH
Watchlist
Price: 14.74 CAD 0.55% Market Closed
Market Cap: 377.2m CAD
Have any thoughts about
Cipher Pharmaceuticals Inc?
Write Note

Cipher Pharmaceuticals Inc
Investor Relations

Cipher Pharmaceuticals, Inc. engages as a specialty pharmaceutical company, which have diversified portfolio of commercial and early to late-stage products. The company is headquartered in Oakville, Ontario. The company went IPO on 2004-02-25. The firm acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products directly in Canada and indirectly through partners in the United States, Canada and South America. Its Dermatology products include Actikerall, Epuris, Ozanex, and Vaniqa. Its Hospital Acute Care products are Aggrastat and Brinavess. The Company’s Out-Licensed Products include Absorica, ConZip, Durela, and Lipofen. The company is focused on three strategy that includes acquisitions, in-licensing, and selective investments in drug development to assemble a portfolio of prescription products that serve unmet medical needs. The firm's subsidiaries include Cipher US Holdings Inc., Cipher US Holdco LLC and Cipher Pharmaceuticals US LLC.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Craig J. Mull
Interim CEO & Chairman of the Board
No Bio Available
Mr. Bryan Jacobs
Chief Financial Officer
No Bio Available
Mr. Emilio Presti
Director of Sales & Marketing
No Bio Available
Dr. Hamed Ghanei
Chief Business Officer
No Bio Available

Contacts

Address
ONTARIO
Oakville
209 Oak Park Blvd, Suite 501
Contacts
+19056025840.0
www.cipherpharma.com